doi:10.7748/ns2008.04.22.30.43.c6440
2024 research from Nutrition & Diabetes outlined the economic impact of obesity related to excess medical costs, absenteeism, disability payments and workers compensation payments
Mire-Sluis AR, Barrett YC, Devanarayan V, Koren E, Liu H, Maia M, et al
It mimics GLP-1 to suppress appetite and slow digestion, leading to better results (average ~15% body weight loss) than older drugs
Heres what you need to know: Patent Expiration and Generic Applications: Novo Nordisks regulatory exclusivity for semaglutide expired on January 4, 2026, clearing the path for generic manufacturers